References
- Gentilini P. Cirrhosis, renal function and NSAIDs. J Hepatol 1993;19:200–3.
- Swan SK, Rudy DW, Lasseter KC, Ryan CF, Buechel KL, et al. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low sodium diet. A randomized, controlled trial. Ann Intern Med 2000;133:1–9.
- Muscara MN, Vergnolle N, Lovren F, Triggle CR, Elliot SN, Asfaha S, et al. Selective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherence. Br J Pharmacol 2000;129:1423–30.
- Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, et al. Effect of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther 1999;289: 735–41.
- Bosch-Marce M, Claria J, Titos E, Masferrer JL, Altuna R, Poo JL. Selective inhibition of cyclooxygenase-2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites. Gastroenterology 1999;116: 1167–75